Encouraging to see this early UK data on the use of chemotherapy in cancer patients during #COVID19 pandemic. There are a number caveats though. Firstly, this is likely to be risk averse data (ie higher risk patients have chemo stopped). We also need dose reduction data #medonc
https://twitter.com/KarinPurshouse/status/1253728555101491203
The reasons for holding back on chemo are numerous. One reason was the fear of hospitals being too full to be able to take in neutropenic sepsis patients and other emergencies. This is now abating and in my region, we can now cautiously treat more patients. #medonc
It’s vitally important for oncologists to have regular local meetings (virtual or social distancing) to update their approaches to using chemo (and other anti-cancer treatments). It’s a fluid situation. #medonc
• • •
Missing some Tweet in this thread? You can try to
force a refresh
